Intellia Therapeutics (NTLA) Stock Chart & Stock Price History $15.41 +0.27 (+1.78%) (As of 03:59 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Intellia Therapeutics Stock Price Performance5 Day Performance+5.84%1 Month Performance-16.34%3 Month Performance-32.60%6 Month Performance-36.23%Year-To-Date Performance-50.64%1 Year Performance-47.67% Receive NTLA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intellia Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad WealthPressCould TSLA reach $500 a share? Free ebook says it’s possible.Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.To claim your copy, follow this link NTLA Stock Chart for Tuesday, November, 5, 2024 NTLA Chart by TradingView Intellia Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$14.81$15.14+2.23%$15.30$14.612.04 million shs$1.54 billion11/01/2024$14.22$14.81+4.15%$14.85$14.011.79 million shs$1.50 billion10/31/2024$14.33$14.22-0.77%$14.52$13.952.60 million shs$1.44 billion10/30/2024$14.99$14.33-4.40%$14.90$14.283.51 million shs$1.46 billion10/29/2024$16.34$14.99-8.26%$16.26$14.704.55 million shs$1.52 billion10/28/2024$15.95$16.34+2.45%$16.98$15.943.24 million shs$1.66 billion Get the Latest News and Ratings for NTLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intellia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$15.85$15.95+0.63%$16.69$15.553.76 million shs$1.62 billion10/24/2024$19.94$15.85-20.51%$17.74$15.3511.37 million shs$1.53 billion10/23/2024$21.08$19.94-5.41%$21.17$19.501.91 million shs$1.92 billion10/22/2024$20.67$21.08+1.98%$21.12$20.221.54 million shs$2.03 billion10/21/2024$21.08$20.67-1.94%$21.09$20.402.37 million shs$1.99 billion10/18/2024$20.98$21.08+0.48%$21.47$20.981.27 million shs$2.03 billion10/17/2024$20.58$20.98+1.94%$21.31$20.432.26 million shs$2.02 billion10/16/2024$19.52$20.58+5.43%$20.85$19.711.89 million shs$1.99 billion10/15/2024$19.51$19.52+0.05%$19.92$19.301.81 million shs$1.88 billion10/14/2024$18.58$19.51+5.01%$19.62$18.232.39 million shs$1.88 billion10/11/2024$17.79$18.58+4.44%$18.60$17.341.48 million shs$1.89 billion10/10/2024$17.65$17.79+0.79%$17.84$17.091.83 million shs$1.72 billion10/09/2024$17.89$17.65-1.34%$18.18$17.451.51 million shs$1.70 billion10/08/2024$17.84$17.89+0.28%$18.00$17.462.09 million shs$1.73 billion10/07/2024$17.99$17.84-0.83%$18.22$17.701.60 million shs$1.72 billion10/04/2024$17.65$17.99+1.93%$18.15$17.431.85 million shs$1.74 billion10/03/2024$18.55$17.65-4.85%$18.37$17.482.00 million shs$1.70 billion10/02/2024$19.20$18.55-3.39%$19.11$18.531.83 million shs$1.79 billion10/01/2024$20.55$19.20-6.57%$20.84$18.962.28 million shs$1.85 billion09/30/2024$21.00$20.55-2.14%$21.39$20.371.10 million shs$1.98 billion09/27/2024$20.57$21.00+2.09%$21.42$20.671.06 million shs$2.03 billion09/26/2024$20.70$20.57-0.60%$21.21$20.231.77 million shs$2.09 billion09/25/2024$21.47$20.70-3.61%$21.87$20.661.27 million shs$2.10 billion09/24/2024$21.46$21.47+0.05%$21.86$21.181.05 million shs$2.07 billion09/23/2024$21.88$21.46-1.92%$21.94$21.441.20 million shs$2.07 billion09/20/2024$22.93$21.88-4.58%$22.70$21.863.14 million shs$2.11 billion09/19/2024$22.52$22.93+1.82%$23.68$22.861.61 million shs$2.21 billion09/18/2024$22.55$22.52-0.13%$23.76$22.261.72 million shs$2.17 billion09/17/2024$21.51$22.55+4.83%$23.15$21.771.47 million shs$2.18 billion09/16/2024$22.07$21.51-2.54%$22.22$21.211.52 million shs$2.18 billion09/13/2024$20.67$22.07+6.77%$22.22$21.002.39 million shs$2.24 billion09/12/2024$20.24$20.67+2.12%$20.68$19.611.52 million shs$1.99 billion09/11/2024$20.12$20.24+0.60%$20.29$19.211.30 million shs$2.06 billion09/10/2024$19.83$20.12+1.46%$20.38$19.311.16 million shs$2.04 billionHas Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover09/09/2024$19.72$19.83+0.56%$20.14$19.521.25 million shs$2.01 billion09/06/2024$20.93$19.72-5.78%$21.33$19.511.42 million shs$1.90 billion09/05/2024$21.27$20.93-1.60%$21.56$20.72982,648 shs$2.02 billion09/04/2024$21.62$21.27-1.62%$22.13$21.08872,623 shs$2.05 billion09/03/2024$22.44$21.62-3.65%$23.08$21.511.53 million shs$2.09 billion09/02/2024$22.44$22.44$23.19$21.931.40 million shs$2.28 billion08/30/2024$23.00$22.44-2.43%$23.19$21.931.40 million shs$2.16 billion08/29/2024$22.35$23.00+2.91%$23.50$22.34935,733 shs$2.22 billion08/28/2024$22.94$22.35-2.57%$23.02$22.09894,309 shs$2.16 billion08/27/2024$23.58$22.94-2.71%$23.62$22.68656,872 shs$2.21 billion08/26/2024$23.63$23.58-0.21%$24.05$23.40805,767 shs$2.27 billion08/23/2024$23.00$23.63+2.74%$24.16$22.851.06 million shs$2.28 billion08/22/2024$23.61$23.00-2.58%$23.64$22.87867,495 shs$2.22 billion08/21/2024$23.18$23.61+1.86%$23.95$23.241.12 million shs$2.28 billion08/20/2024$23.44$23.18-1.11%$23.60$22.99892,390 shs$2.24 billion08/19/2024$22.63$23.44+3.58%$23.50$22.391.18 million shs$2.26 billion08/16/2024$22.87$22.63-1.05%$23.17$22.101.06 million shs$2.18 billion08/15/2024$21.51$22.87+6.32%$23.17$21.821.24 million shs$2.21 billion08/14/2024$22.41$21.51-4.02%$22.73$21.381.56 million shs$2.08 billion08/13/2024$21.77$22.41+2.94%$22.66$21.761.33 million shs$2.16 billion08/12/2024$21.46$21.77+1.44%$21.87$21.011.10 million shs$2.10 billion08/09/2024$22.38$21.46-4.11%$22.61$21.131.43 million shs$2.07 billion08/08/2024$21.31$22.38+5.02%$22.39$20.801.56 million shs$2.16 billion08/07/2024$22.49$21.31-5.25%$23.27$21.241.49 million shs$2.17 billion08/06/2024$22.33$22.49+0.72%$23.02$21.801.05 million shs$2.17 billion08/05/2024$23.85$22.33-6.37%$23.10$21.251.50 million shs$2.15 billion Related Companies Celldex Therapeutics Stock Price Chart Sangamo Therapeutics Stock Price Chart Editas Medicine Stock Price Chart Cellectis Stock Price Chart CRISPR Therapeutics Stock Price Chart Nuvalent Stock Price Chart Blueprint Medicines Stock Price Chart Krystal Biotech Stock Price Chart Avidity Biosciences Stock Price Chart Arcellx Stock Price Chart Receive NTLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Intellia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NTLA) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
